Antibiotics and diuretics are often prescribed concomitantly for humans. We compared the effects of two potent loop diuretics, furosemide and piretanide, with those of water loading on the urinary excretion of cefazolin. During a continuous infusion of inulin and cefazolin (10 mg/kg per h), six healthy male volunteers received a single intravenous injection of furosemide (0.3 mg/kg) or piretanide (0.1 mg/kg) or again an oral water load of 15 ml/kg over a 20-min period. In vitro, furosemide at all concentrations tested significantly reduced by about 10% the percentage of cefazolin bound to serum proteins. Piretanide exhibited such an effect only at a concentration of 2 ,ug/ml. Furosemide, piretanide, and water loading significantly and similarly increased the ratio of excreted to infused cefazolin up to 2 h after the injection of diuretic or after oral water intake. In each of the three parts of the experiment, the increase of the'urinary flow rate was similar when compared with the control values. Furosemide significantly increased the cefazolin filtered load during the same time. Piretanide significantly enhanced the absolute rate of net cefazolin tubular secretion. Water loading increased the urinary excretion of cefazolin, probably through a reduction in tubular reabsorption. These results suggest that (i) furosemide and piretanide as well as water loading are capable of enhancing renal excretion of cefazolin by different complex mechanisms; (ii) cefazolin undergoes a bidirectional tubular transport; (iii) piretanide might act on the proximal tubule in addition to its main 5ite of action on Henle's loop; and (iv) the effects of both diuretics and of water loading are unlikely to affect in vivo antibiotic activity in humans.
Antibiotics and diuretics are often prescribed concomitantly for humans. We compared the effects of two potent loop diuretics, furosemide and piretanide, with those of water loading on the urinary excretion of cefazolin. During a continuous infusion of inulin and cefazolin (10 mg/kg per h), six healthy male volunteers received a single intravenous injection of furosemide (0.3 mg/kg) or piretanide (0.1 mg/kg) or again an oral water load of 15 ml/kg over a 20-min period. In vitro, furosemide at all concentrations tested significantly reduced by about 10% the percentage of cefazolin bound to serum proteins. Piretanide exhibited such an effect only at a concentration of 2 ,ug/ml. Furosemide, piretanide, and water loading significantly and similarly increased the ratio of excreted to infused cefazolin up to 2 h after the injection of diuretic or after oral water intake. In each of the three parts of the experiment, the increase of the'urinary flow rate was similar when compared with the control values. Furosemide significantly increased the cefazolin filtered load during the same time. Piretanide significantly enhanced the absolute rate of net cefazolin tubular secretion. Water loading increased the urinary excretion of cefazolin, probably through a reduction in tubular reabsorption. These results suggest that (i) furosemide and piretanide as well as water loading are capable of enhancing renal excretion of cefazolin by different complex mechanisms; (ii) cefazolin undergoes a bidirectional tubular transport; (iii) piretanide might act on the proximal tubule in addition to its main 5ite of action on Henle's loop; and (iv) the effects of both diuretics and of water loading are unlikely to affect in vivo antibiotic activity in humans.
Antibiotics and diuretics are frequeptly used concomitantly in hupmans in acute severe infections when a rapid onset of diuresis is desired or in patients treated for edema or hypertension and receiving antibiotics for an intercurrent infection. Studies on the effects of furosemide on cephalosporin kinetics in humans have yielded contradictory results (11, 15, 17) . The main purpose of these studies was to explain the potentiation by the diuretic of cephalosporin nephrotoxicity. Little is known, however, about the interaction of these drugs at the renal site of elimination. In a previous report (5), we described important modifications by furosemide of serum protein binding, extravascular diffusion, and renal excretion of cephalosporins in rabbits. The purposes of the present study were to elucidate the mechanisms governing the action of furosemide on the renal excretion of cefazolin in humans and to compare this action with those of water loading and of piretanide, a new potent loop diuretic whose effects in animals are similar to those of furosemide (8 Analysis of samples. Concentrations of cefazolin were determined by high-pressure liquid chromatography as previously described (1) . Concentrations of inulin in plasma and urine were measured by the method of Schreiner (13) . Binding of cefazolin to serum proteins was determined by the standardized ultracentrifugation method (12) . Sedimentation equilibrium studies were performed by mixing cefazolin with 4 (14) . For comparison with control values, we used n = 6 subjects, with 10 degrees of freedom. Differences were considered significant when P < 0.05. Stepwise regression analysis (6) was used to estimate the dependence of cefazolin FE on the cefazolin FL and on cefazolin NTS. RESULTS Protein binding of cefazolin (100 ,ug/ml) in serum amounted to 82%. Furosemide significantly reduced this value when tested in vitro at concentrations of 5, 0.5, or 0.2 p,g/ml.
Binding values in the presence of furosemide were 70, 68, and 76.5%, respectively (P < 0.05).
Piretanide (2 ,ug/ml) significantly reduced cefazolin binding from 82 to 75%. The other concentrations tested (0.2 and 0.02 jig/ml) had no significant effect.
The results obtained for the parameters listed above are 9.0 ± 1.5e 101.5 ± 11.1 8 ± 2e 71 ± 7e 336 ± 40 2,107 ± 280 5.66 ± 0.34e 4,881 ± 970e 82.5 ± 4 4 3.5 ± 0.2e 85.9 ± 6.4e 4 ± le 73 ± 6e 345 ± 37e 1,730 ± 131 5.20 ± 0.27e 5,251 ± 936e 82 ± 2 a Cefazolin was given as described in Table 1 , footnote a. After equilibrium was reached and after two control periods of 30 min each, piretanide (0.1 mg/kg) was injected i.v., and four experimental periods of 30 min each followed. Control and experimental values were described in Table 1 a Cefazolin was given as described in Table 1 , footnote a. After equilibrium was reached and after two control periods of 30 min each, an oral water load (15 ml/kg) was given over 20 min, and four experimental periods of 30 min each followed. Control and experimental values were determined as described in Table 1 given in Tables 1, 2 , and 3, which set forth the effects of furosemide, piretanide, and water loading, respectively, on renal handling of cefazolin. Blood levels of total cefazolin remained constant throughout the four experimental periods of each protocol and were not significantly different from the mean control value (± standard deviation) of 84.7 ± 5 ,g/ml. Urinary pH significantly and progressively declined from a mean control value of 6.83 ± 0.7 during experimental periods 2, 3, and 4 of each protocol. These variations were of the same magnitude for furosemide and piretanide but less pronounced for water loading.
For protocols A, B and C, the results for the five parameters measured in each of the six subjects were averaged (urinary pH, GFR, FE, NTS, and FL). The dependence of cefazolin FE on the cefazolin FL and cefazolin NTS was estimated by stepwise regression as follows: protocol A, FE In protocol B, the participation of FL in the regression equation dropped significantly compared with protocol A (the coefficients 1.192 and 0.743 were significantly different), whereas the participation of the NTS remained unchanged (the coefficients 0.828 and 0.698 were not significantly different). In protocol C, NTS alone accounted for R2 = 0.95 of the total variation in FE around its mean value.
DISCUSSION
During all four experimental periods, we observed that furosemide, piretanide, and water loading had similar effects on the urinary excretion of cefazolin as reflected by the significant increase found in the ratio of excreted to infused drug. However, each subject retained a positive balance of this antibiotic at all times. The mechanisms controlling this increased excretion are obviously different. It should be stressed that in the two protocols involving diuretics, no attempt was made at precise replacement of fluid or electrolyte losses.
With furosemide, we observed a significant increase in the cefazolin FL. This was due in part to the rise in the GFR after the injection of furosemide and also to the reduction by furosemide of cefazolin binding to serum proteins. We previously described a similar pattern for the effects of furosemide on the binding of this antibiotic in rabbits (3). In humans, the displacing effect of furosemide probably lasts longer in view of the levels in plasma reported after a single i.v. injection of 20 mg (16) , which remained over 0.2 ,ugfml for at least 2 h, and of the present results of our in vitro studies of cefazolin binding. We based our calculations of the FL, FE, and absolute rate of cefazolin NTS after furosemide injection on the concentration of free cefazolin in serum. This concentration was calculated from the total serum level of the antibiotic and from the percentage of binding measured in vitro in the presence of various concentrations of the diuretic. This value of serum protein binding varied depending on the experimental period considered (see Tables 1 through 3) . We found that under these conditions, the FE of cefazolin during the control period was 281 ± 23%, indicating marked secretion of this drug by the renal tubules in humans. The main effect of furosemide on the renal handling of cefazolin was glomerular, with no statistically significant net action on the tubules.
The relative potencies of piretanide and furosemide with regard to sodium excretion was described as 2.4:1 by Lawrence et al. (8) . We found that 0.1 mg of piretanide per kg produced a rise in sodium FE similar to that induced by furosemide, except for a significantly higher increase for piretanide during experimental period 2. Although piretanide raised the ratio of excreted to infused cefazolin as much as furosemide did, it only produced a transient increase of the cefazolin FE during the first experimental period. This was due mainly to the fact that the displacing effect of piretanide on cefazolin binding was small and of short duration (about 30 min), in view of the rapid fall (below 0.2 ,g/ml within 30 min) in the levels of piretanide in serum measured after a single i.v. injection of 6 mg and in view of the results of our in vitro cefazolin binding study. Piretanide appeared to raise urinary excretion of cefazolin by a tubular process, as shown by the significant increase in the absolute rate of cefazolin NTS during experimental periods 2, 3, and 4 and by a biphasic (periods 1 and 4) variation of the fractional excretion. These variations appeared to be independant of the variations in urinary pH. These different patterns describing the effect of piretanide on tubular handling of cefazolin seem to indicate the presence of an accessory site of action for piretanide on the proximal tubule, in addition to the main site of Henle's loop. Slight inhibition of sodium reabsorption in the area of the proximal tubule has been suggested by micropuncture studies in rats (10) .
We noted that after water loading, diuresis increased to the same extent as with the diuretics during experimental periods 2, 3, and 4. There was a regular series of changes in the GFR, i.e., a significant drop during experimental periods 2 and 3 (compared with the control) and a return to control level during period 4. Similar changes were described in 1937 by Popper and Mandel (cited by Brod [2] ). They noticed that after water loading, GFR dropped after its transient increase at the peak of diuresis. In our studies, the water load induced no significant change in the cefazolin FL. Its most striking effect was an increase in the NTS of this antibiotic. This appeared in experimental period 1, probably by a reduction of tubular reabsorption. These results suggest that cefazolin reabsorption could also occur in a distal part of the tubule.
Previous studies on rabbits showed that furosemide had an overall effect on the urinary excretion of cefazolin similar to that of water loading (5) . However, the mechanisms involved appeared to be different. In rabbits, the main process occurred at tubular level and was interpreted as either a reduction in reabsorption or an augmentation of tubular secretion. In another study, we described a bidirectional tubular transport of cefazolin revealed by the opposite effects of two different doses of phenylbutazone on cefazolin FE (3). The diphasic response of this FE to the injection of piretanide (a significant fall during experimental period 1 and a significant rise during the last experimental period) might argue for similar behavior in the human tubule.
Tice et al. noted that diuretics had no significant effect on the elimination of cephalothin (15) . It should be recalled that their experimental conditions differed from ours and that when calculating renal clearance of cephalothin they took no account of cephalothin binding to serum proteins or of its possible variations owing to the effect of the diuretics. From the present results, it is possible to conclude that diuretics are liable to interfere with the renal excretion of cephalosporins through several complex mechanisms. These vary according to the properties of the diuretic, i.e., its ability to displace the antibiotic from protein binding and its site of action on the nephron. Kosmidis et al. showed that the relative injection time of the diuretic could modify its effects on renal excretion of cephalosporins (7) . We previously showed that the mode of injection of both diuretic and antibiotic and the compensation for fluid losses could influence these effects (4) .
In the present study, we analyzed the effects of only a single injection of diuretic. However, the fact that all the subjects retained a positive cefazolin balance, combined with our previous findings in rabbits concerning the effects of furosemide on the extravascular diffusion of cephalosporins, justifies the conclusion that the effects of diuretics on in vivo antibiotic activity are probably minimal.
The mechanism causing the changes observed in cefazolin urinary excretion induced by water loading deserve further investigation. The interindividual variations in the kinetics of antibiotics frequently noticed in humans could correspond, at least in part, to unverified variations in diuresis during the experiments.
